AI-generated summary
The authors studied whether transcranial low-level laser therapy affects demyelination in mice given a cuprizone diet. Laser-treated mice showed better motor performance, less demyelination, more oligodendrocyte precursor cells, and milder toxicity than untreated cuprizone mice. The authors suggest laser therapy may be a feasible option for demyelinating diseases, but say further studies are required.
- Who or what was studied
- Mice receiving a cuprizone diet to induce demyelination, plus control mice
- Limits stated in the abstract
- The study was conducted in mice, and the authors state that further studies are required before any conclusions can be drawn.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 36 J/cm2
- Power
- 50 mW
- Total energy
- 1 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.